NZ246195A - Peptides useful as therapeutic agents particularly in feeding inhibition and compositions thereof - Google Patents
Peptides useful as therapeutic agents particularly in feeding inhibition and compositions thereofInfo
- Publication number
- NZ246195A NZ246195A NZ246195A NZ24619592A NZ246195A NZ 246195 A NZ246195 A NZ 246195A NZ 246195 A NZ246195 A NZ 246195A NZ 24619592 A NZ24619592 A NZ 24619592A NZ 246195 A NZ246195 A NZ 246195A
- Authority
- NZ
- New Zealand
- Prior art keywords
- ahx
- gly
- trp
- asp
- hpa
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/595—Gastrins; Cholecystokinins [CCK]
- C07K14/5955—Gastrins; Cholecystokinins [CCK] at least 1 amino acid in D-form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81098591A | 1991-12-20 | 1991-12-20 | |
| GB929220543A GB9220543D0 (en) | 1992-09-29 | 1992-09-29 | Pharmacologically active compounds |
| GB929220761A GB9220761D0 (en) | 1992-10-02 | 1992-10-02 | Pharmaceutically active compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ246195A true NZ246195A (en) | 1995-11-27 |
Family
ID=27266393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ246195A NZ246195A (en) | 1991-12-20 | 1992-12-21 | Peptides useful as therapeutic agents particularly in feeding inhibition and compositions thereof |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0619823A1 (enExample) |
| JP (1) | JPH08500324A (enExample) |
| AU (1) | AU672186B2 (enExample) |
| CA (1) | CA2126236A1 (enExample) |
| FI (1) | FI942898A0 (enExample) |
| HU (1) | HU211564A9 (enExample) |
| IL (1) | IL104161A0 (enExample) |
| MX (1) | MX9207458A (enExample) |
| NO (1) | NO942350L (enExample) |
| NZ (1) | NZ246195A (enExample) |
| WO (1) | WO1993013126A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7762610B2 (ja) * | 2022-03-28 | 2025-10-30 | 雪印メグミルク株式会社 | アンジオテンシン変換酵素阻害ペプチド |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE754248R (fr) * | 1969-08-01 | 1971-02-01 | Farmaceutici Italia | Polypeptides a activite |
| NZ218607A (en) * | 1985-12-19 | 1989-10-27 | Pennwalt Corp | Tri-to acta-peptides with sulphate ester groups: obesity treatment |
| IL84478A0 (en) * | 1986-11-18 | 1988-04-29 | Pennwalt Corp | Peptides with sulfate ester groups and their preparation |
| DE69017704T2 (de) * | 1989-11-27 | 1995-07-20 | Fisons Corp | Hexapeptide mit sulphat-ester-gruppen. |
-
1992
- 1992-12-18 MX MX9207458A patent/MX9207458A/es unknown
- 1992-12-18 IL IL92104161A patent/IL104161A0/xx unknown
- 1992-12-21 NZ NZ246195A patent/NZ246195A/en unknown
- 1992-12-21 CA CA002126236A patent/CA2126236A1/en not_active Abandoned
- 1992-12-21 FI FI942898A patent/FI942898A0/fi not_active Application Discontinuation
- 1992-12-21 JP JP5511269A patent/JPH08500324A/ja active Pending
- 1992-12-21 AU AU31678/93A patent/AU672186B2/en not_active Ceased
- 1992-12-21 WO PCT/GB1992/002369 patent/WO1993013126A1/en not_active Ceased
- 1992-12-21 EP EP93900320A patent/EP0619823A1/en not_active Withdrawn
-
1994
- 1994-06-20 NO NO942350A patent/NO942350L/no unknown
-
1995
- 1995-06-13 HU HU95P/P00191P patent/HU211564A9/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI942898L (fi) | 1994-06-17 |
| AU3167893A (en) | 1993-07-28 |
| IL104161A0 (en) | 1993-05-13 |
| CA2126236A1 (en) | 1993-07-08 |
| NO942350D0 (enExample) | 1994-06-20 |
| WO1993013126A1 (en) | 1993-07-08 |
| FI942898A7 (fi) | 1994-06-17 |
| AU672186B2 (en) | 1996-09-26 |
| FI942898A0 (fi) | 1994-06-17 |
| JPH08500324A (ja) | 1996-01-16 |
| HU211564A9 (en) | 1995-12-28 |
| MX9207458A (es) | 1993-11-01 |
| NO942350L (no) | 1994-06-20 |
| EP0619823A1 (en) | 1994-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4737487A (en) | VIP type peptides | |
| US5681928A (en) | Betides and methods for screening peptides using same | |
| JP3178835B2 (ja) | 新規ポリペプチドおよびこれを用いる抗hiv剤 | |
| US4490364A (en) | CCK Agonists II | |
| JP2569316B2 (ja) | 硫酸エステル基を有するペプチド | |
| US5086042A (en) | Peptides with sulfate ester groups | |
| HU185321B (en) | Process for preparing pharmacologically active ancephaline analogues | |
| EP0268297A2 (en) | Peptides with sulfate ester groups | |
| US4876243A (en) | Vasopressin compounds | |
| NZ246195A (en) | Peptides useful as therapeutic agents particularly in feeding inhibition and compositions thereof | |
| US5502164A (en) | Peptide compounds having therapeutic activity | |
| AU644128B2 (en) | Hexapeptides with sulphate ester groups | |
| JP2001505216A (ja) | ブラジキニンb▲下2▼レセプターのペプチドアゴニスト | |
| SE464814B (sv) | Gonadoliberinderivat innehaallande en beta-aspartylgrupp, ett foerfarande foer framstaellning daerav och farmaceutiska preparat innehaallande desamma | |
| HU201338B (en) | Process for producing peptides and pharmaceutical compositions containing them | |
| AU604785B2 (en) | Peptides with sulfate ester groups | |
| JPH03141298A (ja) | 活性ペプチド | |
| JPS63198699A (ja) | スルフエートエステル基を有するペプチド |